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Abstract
The rapid evolution of influenza viruses occurs both clonally and non-clonally through a variety of genetic mechanisms and
selection pressures. The non-clonal evolution of influenza viruses comprises relatively frequent reassortment among gene
segments and a more rarely reported process of non-homologous RNA recombination. Homologous RNA recombination
within segments has been proposed as a third such mechanism, but to date the evidence for the existence of this process
among influenza viruses has been both weak and controversial. As homologous recombination has not yet been
demonstrated in the laboratory, supporting evidence, if it exists, may come primarily from patterns of phylogenetic
incongruence observed in gene sequence data. Here, we review the necessary criteria related to laboratory procedures and
sample handling, bioinformatic analysis, and the known ecology and evolution of influenza viruses that need to be met in
order to confirm that a homologous recombination event occurred in the history of a set of sequences. To determine if
these criteria have an effect on recombination analysis, we gathered 8307 publicly available full-length sequences of
influenza A segments and divided them into those that were sequenced via the National Institutes of Health Influenza
Genome Sequencing Project (IGSP) and those that were not. As sample handling and sequencing are executed to a very
high standard in the IGSP, these sequences should be less likely to be exposed to contamination by other samples or by
laboratory strains, and thus should not exhibit laboratory-generated signals of homologous recombination. Our analysis
shows that the IGSP data set contains only two phylogenetically-supported single recombinant sequences and no
recombinant clades. In marked contrast, the non-IGSP data show a very large amount of potential recombination. We
conclude that the presence of false positive signals in the non-IGSP data is more likely than false negatives in the IGSP data,
and that given the evidence to date, homologous recombination seems to play little or no role in the evolution of influenza
A viruses.
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Introduction
Influenza A is a rapidly evolving single-stranded negative-sense
RNA virus [1]. More than one hundred antigenic subtypes, each
containing many variants, are maintained in wild aquatic bird
reservoir populations [1–3]. Certain subtypes have jumped species
and established endemic infections among humans, pigs, horses,
and other land and sea mammals [1]. Influenza has shown a
propensity to evolve drug resistance [4–6], escape immunity [7–11],
reassort its RNA segments in multiple host types [2,3,12–17], and
possibly but rarely undergo non-homologous recombination in
which short regions of sequence are transferred among different
segments [18–20]. Despite this varied and dynamic life cycle,
intra-segment homologous RNA recombination has only been
rarely reported in influenza A virus and each of these instances has
proven controversial. Some studies have described sequence
patterns that seem compatible with homologous recombination
events in influenza virus [21–23], but refutations of some of these
observations have been well argued and convincing [24,25]. In
addition, larger-scale bioinformatic analyses found no evidence for
homologous recombination in human influenza A [26] or B [27]
virus, and despite a number of exceptions [28], homologous
recombination is generally thought to be rare in negative-sense
RNA viruses, which may be largely due the presence of a
ribonucleoprotein complex that never disassembles from the RNA
[29,30]. However, the shedding of multiple viruses by waterfowl
has been reported [2], as has mixed infection of humans [31],
providing opportunities for recombination. In addition, recombi-
nation may occur during infection with multiple viruses of
laboratory cell-lines.
Because of its controversial nature and possible implications for
vaccine design, reports of homologous recombination in influenza
virus should be carefully examined to exclude all possible
alternative hypotheses for the putatively observed recombination
event. Some important alternative hypotheses to explore are
contamination of samples, false positive bioinformatic signals, and
alternative evolutionary histories that generated the apparent
recombinants. As a case in point, Krasnitz et al [32] showed that
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contaminants that are labeled with one year but are identical to
viruses isolated decades apart, an example being two nearly-
identical avian sequences isolated in Taiwan in 1972 and 1987.
Similarly, putative recombinants in human H3N2 and H1N1 viral
subtypes were isolated decades apart (e.g. 1968 and 2004) from
their parental sequences [26]. Given the rapid rate of sequence
change in influenza virus, and in particular the rapid rate of viral
lineage turnover in human populations, such evolutionary ‘stasis’
seems untenable. A second common pitfall in recombination
analysis is failing to exclude the possibility of lineage-specific rate
variation. An important case in point concerns the H1N1
influenza A virus associated with the global pandemic of 1918–
1919. Although a homologous recombination event between
human and swine viruses was proposed in this case [21], a later
study showed that the phylogenetic incongruence in this case was
entirely due to contrasting patterns of rate variation [25].
Because of the important yet ongoing controversy over the
occurrence of homologous RNA recombination in influenza A
virus, we herein propose guidelines for how this process can be
reliably detected.
Guidelines
When investigating whether a homologous recombination event
could have occurred during the history of a set of sampled
influenza viruses, (1) laboratory procedures should be optimized to
prevent laboratory-generated artificial recombinants, (2) sequence
data should show a statistically significant recombination signal,
and (3) the putative recombination event should show plausibility
as the most likely hypothesis explaining the data given what is
known about the ecology and evolution of influenza viruses.
Essential Laboratory Procedures
1. Determining if specimens came from co-infected hosts
in the absence of recombination. Samples from co-infected
hosts will have RNA present from multiple viruses [31], and culture
and PCR amplification may result in specific segment sub-regions
being amplified from different viruses, giving the appearance of
homologous intra-segment recombination where none has
occurred. To rule out the possibility that observed recombination
isnotanartifactofsuchco-infection,careshouldbegiventoamplify
and sequence (multiple) clonal virus isolates (biological clones)
generated by plaque purification or limiting dilution culture [26]. If
sequencing is done directly from clinical specimens (without
previous culture), single virus sequencing could be achieved by
limiting dilution PCR, although this is more challenging in view of
low levels of target RNA. Isolating different viruses from multiple
cultures from the same specimen should be the gold-standard
method for determining co-infection of a sample. It is important to
remember that cross-sample contamination may be an additional
mechanism by which multiple viruses are present in culture (see
below).
2. Limiting contamination. The risk of contamination
during virus isolation can be minimized by the use of clean rooms
or, at least, dedicated clean cabinets, for splitting and preparation of
cells, to prevent contamination from infected cell cultures, and by
meticulous experimental design (e.g. including uninfected wells
between different samples when using multi-well plates) and
experimental procedure. As described above, sequencing of
(multiple) biological clones will guarantee that culture conta-
mination, should it occur, will not result in misinterpretation of
possible recombination. During PCR amplification there exist
substantial risks of carryover contamination, particularly by
previously generated amplicons. Besides meticulous laboratory
practice, these risks should be minimized by appropriate laboratory
design and workflow for molecular work, including physical
separation of rooms for preparation of reagents, nucleic acid
extraction, and amplification, respectively, as well as a unidi-
rectional workflow in these respective laboratory rooms. Further
minimization of contamination during pre-sequencing PCR
reactions could be achieved by commercially available uracil-N-
glycosylase-based methods designed to degrade amplicons which
may inadvertently be present in samples before PCR amplification.
Monitoringofpossible PCRcontaminationbyinclusion ofsufficient
negative controls for extraction and amplification steps remains
essential at all times.
Essential Statistical and Bioinformatic Procedures
3. Assessing statistical significance of phylogenetic
recombination signal. The gold-standard bioinformatic
approach to demonstrating the presence of recombination is a set
of statistically incongruent phylogenetic trees. Because searching for
incongruence in trees is extremely laborious when many sequences
are present, the preferred pre-screening approach is to scan large
data sets for mosaic signals, which are simply incongruent trees with
only three sequences included in each tree. Programs such as 3SEQ
[33] and Simplot [34] can be readily used to identify potential
parents and recombinants; these methods also provide recom-
bination breakpoints and P-values assessing the non-randomness of
the mosaic signal. Subsequently, a phylogenetic tree should be
inferred including the recombinant(s), all candidate parental
sequences, and a collection of other sequences that are
representative of the recent and nearby variation in the virus
clades under scrutiny. If bootstrap (or similar) support on the tree
indicates that the recombinant sequences cluster with one parent
group for one sequence region and another parent group for
another sequence region, we consider this a statistically-supported
phylogenetic recombination signal.
4. Checking sequence alignments for possible errors.
Alignment uncertainty can cause discrepancies in phylogenetic
inference [35], and possibly in other bioinformatic analyses.
Alignments should first be verified to ensure that their lengths
correspond to the known segment lengths for influenza A virus.
Subsequently, the alignments can be visually analyzed for obvious
alignment errors; excluding visually misaligned sequences must be
done carefully as true recombinants could also appear to be
misaligned.
Auxiliary Bioinformatic Procedures
5. Determining if breakpoints occur at primer sites.
The occurrence of recombination breakpoints at primer sites
signifies that different regions of multiple gene segments may have
been amplified from a co-infected specimen. A recombination
event with inferred breakpoints away from primer sites would
ensure that this did not happen. However, this condition is clearly
stringent and should be considered carefully as (1) recombination,
if it were to occur, could indeed involve breakpoints close to
primer sites, and (2) breakpoints can either be reported as ranges
(3SEQ) or can vary depending on the choice of a sliding-window
size (SimPlot), making it likely that a true recombination
breakpoint could result in the identification of a breakpoint
range (position) that covers (is close to) a primer site.
Procedures to Assess Compatibility with Known Ecology
and Evolution of Influenza
6. Finding a recombinant clade with sequences isolated
from different animals and preferably by different
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likely to be present as single isolates in phylogenetic trees.
However, the greater the frequency of this putative recombinant
in the circulating virus population, the lesser the probability that it
is a false-positive as this would require multiple identical errors to
be made; this is particularly true if the putative recombinant is
isolated by different laboratories. An important case in point
concerns Ebola virus, where an entire recombinant lineage has
been identified [28], and which also demonstrate that homologous
RNA recombination can indeed occur sporadically in negative-
sense RNA viruses. Ideally, parental sequences should also appear
as clades and not single sequences to ensure that putative parental
sequences did not result from contamination or sequencing error.
7. Assessing compatibility of sampling locations and
sampling times. The most obvious example of a posited recom-
bination event defying reasonable patterns of influenza ecology and
evolution is one in which two human influenza viruses isolated
decadesapartareidentifiedaspossiblyhavingrecombined;therapid
turnover of human influenza virus ensures that viruses isolated more
than five or six years apart will never be isolated in the same host. A
similar, although rather slower lineage turnover, is also seen in the
case of avian [36] and swine [37] viruses. In addition, a recom-
bination event may appear geographically implausible. Equine and
swineinfluenzaviruses,forexample,both exhibitastrong separation
ofAmerican and Eurasian strains [16,38],and recombination events
involving parents located on different continents should be treated
with caution; the global trade in swine and poultry will make some
geographic scenarios more plausible than others [39,40]. Finally, an
obvious signal of a false-positive recombination event is that one of
the putative parents is a viral strain that is commonly used in the
laboratory. As an example, He et al [22] identified A/Taiwan/
4845/99 as a recombinant of A/Wellington/24/2000 and A/
WSN/33, the latter of which is a known laboratory strain and
previously implicated in contamination events [41]. Clearly, a
lineage of naturally occurring influenza virus could not have
persisted from 1933 to the 1990s, nor could an ancient putative
recombinant lineage survive from 1933 to the 1990s.
8. Determining plausibility of lineage-specific rate
variation. As noted previously, lineage-specific rate variation
(heterotachy) can produce a mosaic signal identical to one that
would be seen under homologous recombination [25,33].
Specifically, if region A is highly conserved in lineage A, and if
region B is highly conserved in lineage B, then any sampled
sequence that has evolved in a third separate lineage will appear to
be similar to lineage-A sequences in region A and similar to
lineage-B sequences in region B, thus appearing to be a mosaic of
sequences from lineages A and B. See Boni et al [33] and Worobey
et al [25] for examples of how lineage-specific rate variation can
cause apparent mosaicism.
Previously identified homologous recombinants in
influenza
We know of only three peer-reviewed articles that have
proposed the occurrence of homologous intra-segment recombi-
nation in influenza virus [21–23].
As described previously, Gibbs et al [21] suggested that the HA
segmentofthe1918H1N1viruswasarecombinant betweena swine
virusandahuman virus.However,thisclaimwasstronglyrefuted by
Worobey et al [25], primarily because of a lack of phylogenetic
support for the recombination signal and the inability to exclude the
alternative hypothesis of lineage-specific rate variation.
He et al [22] present two Canadian swine viruses isolated in
2003, one human H1N1 virus isolated in Taiwan in 1999, and one
human H3N2 virus isolated in Hong Kong in 1997 as probable
homologous recombinants. One of the Canadian recombination
events requires a parental sequence from 1960, and the Taiwanese
recombinant requires the laboratory strain A/WSN/33(H1N1) as
one of its parents, strongly suggesting that these putative
recombination events are erroneous.
The PB2 gene of the A/Swine/Ontario/53518/03 virus has
putative parental sequences from 2002 (Korea) and 2003 (Alberta)
making it a more plausible recombinant, although it does contain
parental strains sampled from different continents. It is identified
as a mosaic sequence by 3SEQ (at the same breakpoint) and has a
statistically-supported phylogenetic recombination signal in an ML
tree constructed by RAxML [42,43] (analysis not shown).
However, in order to infer this tree, all North American and
Asian swine H1Nx sequences since 1970 were downloaded from
the Influenza Virus Resource, and no other sequence clusters with
A/Swine/Ontario/53518/03, making it the lone recombinant out
of 181 sequences.
The NP segment of the human H3N2 sequence A/Hong
Kong/498/97 has putative parents in Hong Kong (1997 and
1998). This sequence is also identified as a mosaic by 3SEQ (with
the same breakpoint), but phylogenetic analysis of the shorter
region (223nt) does not produce a statistically-supported clade
containing the recombinant and one of the parents (analysis not
shown). A total of 517 public H1N1 and H3N2 human sequences
were downloaded to infer this tree, and not a single sequence
showed the same putative recombination event as A/Hong Kong/
498/97; consequently, evidence is lacking for a recombinant clade
of viruses like A/Hong Kong/498/97.
The second He et al [23] study presents three avian H9N2
viruses that they sampled, plaque-purified, and sequenced – A/
chicken/Guangxi/1/00, A/chicken/Guangxi/14/00, A/chick-
en/Guangxi/17/00 – and an additional 41 sequences that the
authors downloaded from GenBank and analyzed with SimPlot.
The three Guangxi viruses appear to have a mosaic PA segment
that also has a statistically-supported phylogenetic signal, and
which therefore constitute the closest example we have seen thus
far of a recombinant clade, although it is noteworthy that they
were obtained in the same laboratory. Here, investigating
guidelines 2 and 5 further would give us some certainty as to the
veracity of these recombinant sequences. Indeed, it is important to
note that the parental sequences for these three putative
recombinants were identified in GenBank, and their sample-
handling and sequencing are of unknown quality.
The remaining 41 recombinants are shown with phylogenies
and SimPlot graphs in the supplementary materials (Figures S1,
S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16,
S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29,
S30, S31, S32, S33, S34, S35, S36, S37, S38 in the He et al paper).
These are mainly H5N1 and H9N2 chicken isolates from China,
and 31 of the recombination events occur in the polymerase genes,
which are the longest segments with the most number of individual
contigs. As we show in the next section, downloading sequences
from GenBank without controlling for quality can lead to the
inclusion of many sequences from contaminated samples which
can generate false-positive recombination signals.
Controlling for quality in the influenza sequence
database
To provide some control for quality of sequencing, we can
separate the database of all publicly available influenza sequences
into those that were sequenced by the Influenza Genome
Sequencing Project and those that were not. Importantly,
sequence data generated under the IGSP are subject to very strict
quality control, manifest as a high level of redundancy.
Guidelines Flu Recombination
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cons and overlapping amplicons, so that each nucleotide is covered
by at least two separate amplicons and each amplicon is sequenced
at least twice in both the forward and reverse directions [44].
To assess the possible effect of sequencing quality on detection
of recombination signals, we performed a recombinant search on
IGSP and non-IGSP avian influenza viruses, isolated from birds
and humans, similar to the search and analysis in Boni et al [26].
Identification of recombinants is done according to the guidelines
defined in this paper.
Methods
All influenza sequences were downloaded from the Influenza
Virus Resource (http://www.ncbi.nlm.nih.gov/genomes/FLU/
Database/select.cgi) on March 18–20, 2009, excluding seasonal
human H3N2 and seasonal human H1N1 as these were analyzed
elsewhere [26]. Data sets that had a sizeable contribution (.30) of
both IGSP sequences and non-IGSP sequences were aligned with
MUSCLE v3.6 [45] and analyzed for recombination signals using
the 3SEQ algorithm [33,46]. 3SEQ tests all possible triplets in a
data set for a mosaic recombination signal using a nonparametric
statistic for mosaicism. 3SEQ also infers breakpoints and reports
likely breakpoint ranges.
MUSCLE alignments were inspected visually to remove sequenc-
es that were obvious alignment errors. Hence, GenBank accession
number DQ997359 (non-IGSP) was removed from the avian/
H5N1/PA data set, while GenBank accession number DQ997548
(non-IGSP)was removed from theavian/H5N1/NA data set. Three
IGSP sequences (CY029003, CY015123, CY031005) and 14 non-
IGSP sequences (AF144307, AY059499, AF216718, AF216726,
AF216734, AF216710, AY059502, AY059503, AY059501,
FJ434376, EU636696, U85447, U85380, AY028445)wereremoved
from the avian/H5N1/NS data set. Two IGSP sequences
(CY005144, CY005877) and 11 non-IGSP sequences (AF156485,
EU982320, AF156484, EU982312, AY633280, AF508712,
AF523504, AB256686, AB256718, AF523503, AF523505) were
removed from the avian/H9N2/NS data set. Removing these
misaligned sequences had no effect on the IGSP recombination
analysis and inconsequential effects on the non-IGSP analysis.
Candidate recombinant sequences were identified as having a
corrected P-value,0.05 as determined by 3SEQ’s nonparametric
D-statistic [33]. All candidate recombinants were then filtered to
retain only those where both putative recombinant regions were
longer than 100nt, so that phylogenetic trees could be reasonably
inferred for both regions. Phylogenetic incongruence was again
utilized as the gold-standard bioinformatic method for the
identification of recombinant sequences. Maximum likelihood
(ML) trees were inferred with PAUP* [47] and RAxML [42,43];
bootstrap analysis was performed with RAxML. A total of 6110
non-IGSP sequences and 2197 IGSP sequences were tested for
homologous recombination with 3SEQ by testing for recombina-
tion signals in all possible sequence triplets within each of the 18
data sets described in Table 1.
To test if the strong recombination signals detected in the non-
IGSP data sets could result from false positive identification by the
Table 1. Summary of 18 datasets used in this study.
number of
sequences
segregating
sites
Watterson’s
h P-value
number of
recombinant
sequences
number of
recombinant
sequences
.100nt
number of
bootstrap-
supported
phylogenetic
recombination
signals
host subtype segment
non-
IGSP IGSP
non-
IGSP IGSP
non-
IGSP IGSP
non-
IGSP IGSP
non-
IGSP IGSP
non-
IGSP IGSP IGSP
avian H5N1 PB2 402 114 1279 844 0.089 0.074 0 1.63610
23 387 1 382 0 0
PB1 374 219 1112 870 0.079 0.068 10
229 2.87610
25 337 182 335 0 0
PA 494 227 1226 834 0.085 0.066 10
236 1.04610
25 465 16 465 16 1
HA 1155 230 1218 759 0.095 0.077 10
28 0.00278 101 1 6 0 0
NP 495 200 759 494 0.077 0.058 10
225 0.00265 423 1 95 0 0
NA 829 222 951 614 0.093 0.075 10
210 6.52610
26 201 9 67 0 0
MP 440 116 466 237 0.068 0.044 10
26 0.313 72 0 54 0 0
NS 566 193 530 298 0.092 0.063 10
27 1 335 0 190 0 0
human H5N1 PB2 55 42 606 202 0.064 0.023 3.24610
25 0 . 3 2 3 4 03 00
PB1 62 41 501 196 0.049 0.021 0.0108 1 3 0 3 0 0
PA 65 44 563 179 0.06 0.021 2.96610
25 1 7 00 00
HA 142 48 581 185 0.065 0.026 0.0254 1 3 0 0 0 0
NP 60 43 297 107 0.046 0.018 10
27 1 7 00 00
NA 151 41 564 137 0.075 0.025 10
28 1 106 0 54 0 0
MP 63 40 189 75 0.044 0.02 8.04610
25 0.999 13 0 13 0 0
NS 67 33 199 60 0.052 0.019 0.974 1 0 0 0 0 0
avian H9N2 NA 377 190 966 658 0.109 0.084 10
216 10
210 159 39 119 33 1
NS 313 154 498 352 0.095 0.077 0.628 1 0 0 0 0 0
Footnotes: P-values are corrected with a Dunn-Sidak correction for the numbers of triplets tested in each dataset. P-values are shown as simple orders of magnitude
when P,10
26.
doi:10.1371/journal.pone.0010434.t001
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data with the numbers of sequences, models of evolution, and
diversity parameters mimicking those of the non-IGSP data sets.
Models of evolution were evaluated using MODELTEST [48]; for
each sequence set, GTR+C was either the best model or within the
95% confidence bounds given by the Akaike Information
Criterion. For each of the 18 non-IGSP data sets, 100 clonal
data sets – of the same size, diversity, and evolved under the same
GTR+C model – were generated using Treevolve [49]. These
186100 clonal data sets were analyzed by 3SEQ for recombina-
tion signals; results are in Table 2.
Results
A total of 1786 (29%) non-IGSP sequences had recombination
regions of sufficient length (.100nt) to be tested by phylogenetic
inference, while only 49 (2%) of IGSP sequences had such signals.
In the non-IGSP set, 31% of all avian sequences had putative
recombinant regions .100nt, while 11% of all human sequences
had putative recombinant regions .100nt. Sixteen of the putative
IGSP recombinants were avian H5N1 sequences of the influenza
PA gene segment (acidic subunit of the RNA polymerase). The
remaining 33 were avian neuraminidase (NA) sequences of the
H9N2 subtype. These 49 sequences represent 2.6% of all avian
IGSP sequences. The putative IGSP recombinants are considered
in detail below.
For the PA gene, the breakpoint pair 1361/1938 resulted in one
candidate recombinant (A/Muscovy Duck/Vietnam/NCVD-22/
2007), and the breakpoint pair 139/2015 corresponded to the
other 15 putative recombinants. The pair 139/2104 was also
considered but did not show any phylogenetic recombination
signal (results not shown).
The inferred phylogenies of the ‘major’ (bases 1–1361 and
1939–2314) and ‘minor’ (bases 1362–1938) regions of the avian
H5N1 PA gene are shown in Figure 1. The blue and green colored
sequences in these figures were identified as the major and minor
parental sequences, respectively, by 3SEQ. The putative recom-
binant A/Muscovy Duck/Vietnam/NCVD-22/2007 appears to
jump clades in these two phylogenies, and its clustering with the
blue clade in one tree and the green clade in the second tree is
supported by bootstrap percentages of 100 and 91, respectively,
making this a well-supported phylogenetic recombination signal.
Figure 2 shows the same 45 sequences as Figure 1, but with the
major region now defined as bases 1–139 and 2016–2314, and the
minor region as bases 140–2015. Fifteen sequences were identified
by 3SEQ as having mosaic signals that corresponded to these
breakpoints, but only one sequence (A/Duck/Vietnam/NCVD-
31/2007) exhibits phylogenetic incongruence in these trees.
Unfortunately, the major region is relatively short (438nt), and a
robust tree cannot be easily inferred. Low levels of bootstrap
support and the putative recombinant not clustering with the
parental sequences in Figure 2A indicate that we have little
compelling evidence supporting the PA segment of A/Duck/
Vietnam/NCVD-31/2007 as a true homologous recombinant.
For the NA gene, the breakpoint pair 479/925 corresponded to
32 candidate recombinants. The twelve sequences with the
strongest signals are included in the trees in Figure 3; a full
analysis with all 32 candidate recombinants only showed one (A/
Partridge/Shantou/645/2001) with a phylogenetically supported
recombination signal. A large number of candidate major parents
(6) and minor parents (17) results in a very pronounced
phylogenetic recombination signal in Figure 3. High levels of
bootstrap support ($90) on various branches separating the
recombinant from the parents suggest that the phylogenetic
recombination signal for A/Partridge/Shantou/645/2001 is
statistically significant.
The breakpoint pair 219/720 corresponded to one putative
recombinant (A/Partridge/Shantou/7075/2004) shown in
Figure 4. The tree inferred for the minor segment (Figure 4A)
supports a small degree of phylogenetic incongruence, but not
indicative of homologous recombination of the given parental
sequences, or any other sequences in this tree.
In summary, of these four recombination scenarios, two had
phylogenetically supported recombination signals (Figures 1 and
3); however, in both of these cases, we see only a single circulating
recombinant sequence such that they cannot be assigned with any
certainty.
Because of the large number of recombination signals in the
non-IGSP data, there was no sensible way to choose a subset for
phylogenetic analysis. The signals detected in the non-IGSP data
represent either (i) true recombination, (ii) false-positive recombi-
nation signals resulting from sequencing error or sample
contamination, or (iii) false positives generated by the 3SEQ
algorithm. To eliminate the last of these three hypotheses, we
tested if 3SEQ has an unusually high rate of false positives on data
sets with parameters similar to the examined non-IGSP data by
simulating 100 clonal versions of each of the 18 non-IGSP data
sets used in this study. Table 2 shows that false positive signals
would not be expected in such data sets when they are truly clonal,
even if the multiple comparisons correction (Dunn-Sidak) in 3SEQ
were relaxed by an order of magnitude.
Discussion
Of the 2197 IGSP sequences analyzed in this study, only two
had both a statistically significant mosaic signal and bootstrap-
Table 2. False positives of 3SEQ algorithm on simulated
clonal data sets of the same size and diversity as in this study.
host subtype segment
number of 3SEQ
false positives
using P,.05
number of 3SEQ
false positives
using P,.50
human H5N1 PB2 1 / 100 3 / 100
H5N1 PB1 0 / 100 0 / 100
H5N1 PA 0 / 100 1 / 100
H5N1 HA 0 / 100 1 / 100
H5N1 NP 0 / 100 3 / 100
H5N1 NA 0 / 100 0 / 100
H5N1 MP 1 / 100 2 / 100
H5N1 NS 0 / 100 1 / 100
avian H5N1 PB2 0 / 100 1 / 100
H5N1 PB1 0 / 100 0 / 100
H5N1 PA 0 / 100 1 / 100
H5N1 HA 0 / 100 0 / 100
H5N1 NP 0 / 100 1 / 100
H5N1 NA 0 / 100 0 / 100
H5N1 MP 0 / 100 0 / 100
H5N1 NS 0 / 100 0 / 100
avian H9N2 NA 0 / 100 0 / 100
H9N2 NS 0 / 100 1 / 100
Footnote: P-value in the column heading is the Dunn-Sidak corrected P-value.
doi:10.1371/journal.pone.0010434.t002
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PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10434Figure 1. Bootstrapped ML trees, inferred with RAxML, for regions of the PA segment of avian H5N1 sequences. Tree A was inferred
for the region defined by positions 1–1361 & 1939–2314. Tree B was inferred for the region defined by positions 1362–1938. The red sequence is the
putative recombinant sequence. Blue and green sequences are major and minor parental sequences, respectively, as identified by 3SEQ. Trees are
midpoint rooted. ML trees inferred with PAUP* have some non-critical differences the two subclades marked with open circles.
doi:10.1371/journal.pone.0010434.g001
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PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10434Figure 2. Bootstrapped ML trees for the PA segment of avian H5N1 sequences. Tree A was inferred for the region defined by positions 1–
139 & 2016–2314. Tree B was inferred for the region defined by positions 140–2015. ML trees inferred with PAUP* have some non-critical differences
the two subclades marked with open circles. Phylogenetic relationships in these trees do not support a hypothesis of homologous recombination.
Other features as in Figure 1.
doi:10.1371/journal.pone.0010434.g002
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PLoS ONE | www.plosone.org 7 May 2010 | Volume 5 | Issue 5 | e10434Figure 3. Bootstrapped ML trees for the NA segment of avian H9N2 sequences. Tree A was inferred for the region defined by positions 1–
479 & 926–1496. Tree B was inferred for the region defined by positions 480–925. ML trees inferred with PAUP* have identical topology to the trees
shown here. Other features as in Figure 1.
doi:10.1371/journal.pone.0010434.g003
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PLoS ONE | www.plosone.org 8 May 2010 | Volume 5 | Issue 5 | e10434Figure 4. Bootstrapped ML trees for the NA segment of avian H9N2 sequences. Tree A was inferred for the region defined by positions 1–
219 & 721–1496. Tree B was inferred for the region defined by positions 220–720. ML trees inferred with PAUP* have identical topology to the trees
shown here. Phylogenetic relationships in these trees do not support a hypothesis of homologous recombination. Other features as in Figure 1.
doi:10.1371/journal.pone.0010434.g004
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PLoS ONE | www.plosone.org 9 May 2010 | Volume 5 | Issue 5 | e10434supported recombination signal: the PA segment of A/Muscovy
Duck/Vietnam/NCVD-22/2007 (H5N1) and the NA segment of
A/Partridge/Shantou/645/2001 (H9N2). While the recombina-
tion signals for these sequences seem relatively strong, it is telling
that no other samples (IGSP or non-IGSP) had sequences similar
at the nucleotide level to these two apparent recombinants. This
can mean one of a number of things: (i) that homologous
recombination is extremely rare, (ii) that homologous recombina-
tion produces non-viable viruses which cannot be sampled, or (iii)
that these samples are not in fact true recombinants. Identification
of a circulating clade of recombinant viruses, rather than a lone
recombinant sequence, would provide far more compelling
evidence that intra-segmental homologous recombination occurs
among influenza viruses.
If we assume that the sequences generated through the Influenza
Genome Sequencing Project are less likely to be contaminated or to
contain fewer sequencing errors because of the rigorous quality
control used, then the large number of recombination signals
present in the non-IGSP data may not reflect the true evolutionary
history of these sequences, especially when we note that for some of
the longer segments (PB2, PB1, PA), more than 90–95% of non-
IGSP sequences were flagged as recombinant. As viruses sequenced
through the IGSP should not recombine more or less frequently
than viruses sequenced otherwise, either the non-IGSP recombi-
nants are false positivesor we have failed to identify true instances of
recombination in the IGSP data sets. As 3SEQ has very high power
to detectrecombinationsignals [33],especiallyindata setswithhigh
nucleotide diversity, it is unlikely that we missed scores or hundreds
of recombination signals in the 2197 IGSP sequences considered.
The more likely scenario is that the non-IGSP signals are false
positives.
It is therefore our belief that the true level of homologous
recombination is likely to be overestimated in bioinformatic
analyses that broadly include all influenza data available in
GenBank, especially for avian viruses since birds appear to be very
commonly co-infected [2]. It is not true that non-IGSP GenBank
sequences must necessarily be low quality, as the large majority of
these sequences probably have no sequencing error and come
from laboratories where samples are handled very carefully.
Rather, the large number of candidate recombinants present in
the non-IGSP columns of Table 1 reflects the fact that one
recombinant sequence can generate many mosaic signals as it can
also be identified as a major or minor parent in the analysis. In the
avian PB1 data set, for example, 41 sequences (11%) can be
removed and the recombination signal for PB1 disappears
altogether, indicating that it is a minority of problematic sequences
responsible for the strong recombination signals in the non-IGSP
data sets.
As the influenza virus sequence database grows — especially in
the next few years as the initial evolution of 2009 H1N1 is tracked
— and as advances in computing power and bioinformatic
methods are able to handle larger volumes of sequence data, it is
clearly of utmost importance not to lose track of sequence quality
and sample quality as important prerequisites for the validity of
analyses carried out on large data sets.
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